Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy.
Yu ImaiNobuyoshi KosakaKosuke IwataniMinoru NakazonoKojiro TashiroMariko HondaManabu AokiShun SatoHiroyuki TakahashiKenta MikiTakahiro KimuraPublished in: International journal of clinical oncology (2023)
Our analysis of long-term outcomes in patients with high-risk localized prostate cancer shows no significant differences in oncological outcomes between LDR-BT and HDR-BT, but some differences in toxicity, and offers patients and clinicians useful information in deciding management strategies for high-risk localized prostate cancer.
Keyphrases
- prostate cancer
- radical prostatectomy
- high dose
- end stage renal disease
- radiation therapy
- ejection fraction
- chronic kidney disease
- low dose
- newly diagnosed
- stem cell transplantation
- locally advanced
- palliative care
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- healthcare
- radiation induced
- health information
- type diabetes
- monte carlo